253 related articles for article (PubMed ID: 25340782)
1. IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.
Bhattacharyya T; Ayandeh A; Falconar AK; Sundar S; El-Safi S; Gripenberg MA; Bowes DE; Thunissen C; Singh OP; Kumar R; Ahmed O; Eisa O; Saad A; Silva Pereira S; Boelaert M; Mertens P; Miles MA
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3273. PubMed ID: 25340782
[TBL] [Abstract][Full Text] [Related]
2. Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
Marlais T; Bhattacharyya T; Singh OP; Mertens P; Gilleman Q; Thunissen C; Hinckel BCB; Pearson C; Gardner BL; Airs S; de la Roche M; Hayes K; Hafezi H; Falconar AK; Eisa O; Saad A; Khanal B; Bhattarai NR; Rijal S; Boelaert M; El-Safi S; Sundar S; Miles MA
Front Cell Infect Microbiol; 2018; 8():427. PubMed ID: 30619774
[No Abstract] [Full Text] [Related]
3. Detection of Immunoglobulin G1 Against rK39 Improves Monitoring of Treatment Outcomes in Visceral Leishmaniasis.
Mollett G; Bremer Hinckel BC; Bhattacharyya T; Marlais T; Singh OP; Mertens P; Falconar AK; El-Safi S; Sundar S; Miles MA
Clin Infect Dis; 2019 Sep; 69(7):1130-1135. PubMed ID: 30541022
[TBL] [Abstract][Full Text] [Related]
4. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
[TBL] [Abstract][Full Text] [Related]
5. Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.
Bhattacharyya T; Bowes DE; El-Safi S; Sundar S; Falconar AK; Singh OP; Kumar R; Ahmed O; Boelaert M; Miles MA
PLoS Negl Trop Dis; 2014 Feb; 8(2):e2675. PubMed ID: 24587456
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients.
Anam K; Afrin F; Banerjee D; Pramanik N; Guha SK; Goswami RP; Gupta PN; Saha SK; Ali N
Clin Diagn Lab Immunol; 1999 Mar; 6(2):231-5. PubMed ID: 10066659
[TBL] [Abstract][Full Text] [Related]
7. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
Owen SI; Hossain F; Ghosh P; Chowdhury R; Hossain MS; Jewell C; Cruz I; Picado A; Mondal D; Adams ER
Parasit Vectors; 2021 Feb; 14(1):111. PubMed ID: 33597000
[TBL] [Abstract][Full Text] [Related]
8. Validation of rK39 immunochromatographic test and direct agglutination test for the diagnosis of Mediterranean visceral leishmaniasis in Spain.
Bangert M; Flores-Chávez MD; Llanes-Acevedo IP; Arcones C; Chicharro C; García E; Ortega S; Nieto J; Cruz I
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006277. PubMed ID: 29494596
[TBL] [Abstract][Full Text] [Related]
9. Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse.
Mondal D; Ghosh P; Chowdhury R; Halleux C; Ruiz-Postigo JA; Alim A; Hossain F; Khan MAA; Nath R; Duthie MS; Kroeger A; Matlashewski G; Argaw D; Olliaro P
Front Microbiol; 2019; 10():2268. PubMed ID: 31649631
[TBL] [Abstract][Full Text] [Related]
10. Laboratorial algorithm for serological diagnosis of visceral leishmaniasis using rK39-ICT, DAT-LPC and FC-Simplex IgG1.
do Vale INPC; Saliba JW; Fonseca GSF; Peruhype-Magalhães V; de Araújo FF; Pascoal-Xavier MA; Teixeira-Carvalho A; Campos FMF; Andrade MC; Lula JF; Reis AB; Lemos EM; de Carvalho SFG; Oliveira E; Martins-Filho OA
J Immunol Methods; 2020 May; 480():112765. PubMed ID: 32119888
[TBL] [Abstract][Full Text] [Related]
11. The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients.
Elassad AM; Younis SA; Siddig M; Grayson J; Petersen E; Ghalib HW
Clin Exp Immunol; 1994 Feb; 95(2):294-9. PubMed ID: 8306504
[TBL] [Abstract][Full Text] [Related]
12. Refining wet lab experiments with in silico searches: A rational quest for diagnostic peptides in visceral leishmaniasis.
Bremer Hinckel BC; Marlais T; Airs S; Bhattacharyya T; Imamura H; Dujardin JC; El-Safi S; Singh OP; Sundar S; Falconar AK; Andersson B; Litvinov S; Miles MA; Mertens P
PLoS Negl Trop Dis; 2019 May; 13(5):e0007353. PubMed ID: 31059497
[TBL] [Abstract][Full Text] [Related]
13. rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.
Abass E; Bollig N; Reinhard K; Camara B; Mansour D; Visekruna A; Lohoff M; Steinhoff U
PLoS Negl Trop Dis; 2013; 7(7):e2322. PubMed ID: 23875052
[TBL] [Abstract][Full Text] [Related]
14. Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment.
Hossain F; Ghosh P; Khan MAA; Duthie MS; Vallur AC; Picone A; Howard RF; Reed SG; Mondal D
PLoS One; 2017; 12(9):e0185606. PubMed ID: 28957391
[TBL] [Abstract][Full Text] [Related]
15. Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.
Singh OP; Gidwani K; Kumar R; Nylén S; Jones SL; Boelaert M; Sacks D; Sundar S
Clin Vaccine Immunol; 2012 Jun; 19(6):961-6. PubMed ID: 22539471
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.
Ejazi SA; Bhattacharya P; Bakhteyar MA; Mumtaz AA; Pandey K; Das VN; Das P; Rahaman M; Goswami RP; Ali N
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005035. PubMed ID: 27741241
[TBL] [Abstract][Full Text] [Related]
17. Performance of rK39-based immunochromatographic rapid diagnostic test for serodiagnosis of visceral leishmaniasis using whole blood, serum and oral fluid.
Sanchez MCA; Celeste BJ; Lindoso JAL; Fujimori M; de Almeida RP; Fortaleza CMCB; Druzian AF; Lemos APF; de Melo VCA; Miranda Paniago AM; Queiroz IT; Goto H
PLoS One; 2020; 15(4):e0230610. PubMed ID: 32240188
[TBL] [Abstract][Full Text] [Related]
18. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
[TBL] [Abstract][Full Text] [Related]
19. Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.
Ravindran R; Anam K; Bairagi BC; Saha B; Pramanik N; Guha SK; Goswami RP; Banerjee D; Ali N
Infect Immun; 2004 Feb; 72(2):863-70. PubMed ID: 14742530
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of anti-gal enzyme-linked immunosorbent assay for the diagnosis of Indian post-kala-azar dermal leishmaniasis.
Datta S; Ghosh M; Sarkar S; Saha B; Mukhopadhyay S
Indian J Dermatol Venereol Leprol; 2019; 85(6):578-589. PubMed ID: 31397399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
